| Name | 4-methoxy-5-(3-morpholin-4-ylpropoxy)-2-nitrobenzonitrile |
|---|---|
| Synonyms |
Benzonitrile, 4-methoxy-5-[3-(4-morpholinyl)propoxy]-2-nitro-
y6567 4-Methoxy-5-[3-(4-morpholinyl)propoxy]-2-nitrobenzonitrile 4-Methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile 2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile Benzonitrile,4-methoxy-5-[3-(4-morpholinyl)propoxy]-2-nitro- |
| Description | Gefitinib impurity 1 is the impurity of Gefitinib. Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy. Gefitinib has antitumour activity[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 522.3±50.0 °C at 760 mmHg |
| Molecular Formula | C15H19N3O5 |
| Molecular Weight | 321.328 |
| Flash Point | 269.7±30.1 °C |
| Exact Mass | 321.132477 |
| PSA | 100.54000 |
| LogP | 1.50 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.570 |
| Hazard Codes | Xi |
|---|
|
~96%
675126-26-8 |
| Literature: Wang, Ji-Quan; Gao, Mingzhang; Miller, Kathy D.; Sledge, George W.; Zheng, Qi-Huang Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 15 p. 4102 - 4106 |
|
~%
675126-26-8 |
| Literature: WO2005/70909 A1, ; Page/Page column 25-26 ; |
|
~%
675126-26-8 |
| Literature: Heterocycles, , vol. 71, # 1 p. 39 - 48 |
|
~%
675126-26-8 |
| Literature: Heterocycles, , vol. 71, # 1 p. 39 - 48 |
|
~%
675126-26-8 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 15 p. 4102 - 4106 |
|
~%
675126-26-8 |
| Literature: Heterocycles, , vol. 71, # 1 p. 39 - 48 |
|
~%
675126-26-8 |
| Literature: Heterocycles, , vol. 71, # 1 p. 39 - 48 |
| Precursor 6 | |
|---|---|
| DownStream 5 | |